RA Capital Management
150 portfolio companies · 92 on the map · $6.7B raised · 55 cities
Portfolio map
92 RA Capital Management portfolio companies on the map.
Portfolio companies

Janux Therapeutics
San Diego
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Biotechnology Research$898.9MEst. 2017
Arcutis Biotherapeutics
Westlake Village
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Biotechnology Research$833.5MEst. 2016
Compass Pathways
London
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Mental Health Care$771.2MEst. 2016
Mineralys Therapeutics
Radnor
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Biotechnology Research$740.5MEst. 2020Hiring fast
Avalo Therapeutics
Chesterbrook
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Biotechnology$606.5MEst. 2011
CG Oncology
Dallas
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Biotechnology Research$555.6MEst. 2010
Synthego
Menlo Park
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Biotechnology Research$459.7MEst. 2012
Alentis Therapeutics
Allschwil
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Pharmaceutical Manufacturing$365.4MEst. 2019
Stoke Therapeutics
Bedford
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Biotechnology Research$360.1MEst. 2017
LENZ THERAPEUTICS
San Diego
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Pharmaceutical Manufacturing$217.4M
Spyglass Pharma
Aliso Viejo
Spyglass Pharma provides medicine for ophthalmic diseases.
Pharmaceutical Manufacturing$184.8MEst. 2019
Ceribell
Sunnyvale
Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.
Medical Equipment Manufacturing$171MEst. 2014
Superluminal Medicines
Boston
Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
Biotechnology Research$153M
Cytek Biosciences
Fremont
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Biotechnology Research$144.3MEst. 1992- TB
TORL BioTherapeutics
Culver City
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Biotechnology Research$96MEst. 2018 
Synapticure
Chicago
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
Hospitals and Health Care$78.2MEst. 2019
ARS Pharmaceuticals Operations
San Diego
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
Pharmaceutical Manufacturing$75MEst. 2015Plexium
San Diego
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Biotechnology ResearchSeries CEst. 2018- KA
Kadmon, a Sanofi Company
New York
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Biotechnology ResearchPublic - TN
Trace Neuroscience
South San Francisco
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Biotechnology ResearchSeries AEst. 2024 - S
Synthorx
La Jolla
Synthorx is a biotechnology company using synthetic biology to synthesize solutions.
Biotechnology ResearchSeries CEst. 2014 - SD
Selux Diagnostics
Boston
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
Biotechnology ResearchSeries DEst. 2014 Tenaya Therapeutics
South San Francisco
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Biotechnology ResearchPublicEst. 2016CORXEL Pharmaceuticals
Berkeley Heights
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Biotechnology ResearchSeries DEst. 2019Ajax Therapeutics
Cambridge
Cambridge-based.
Series CBambusa Therapeutics
Boston
Boston-based.
Series AForge Biologics
Grove City
Grove City-based.
Series BVitriVax
Boulder
Boulder-based.
Series BCortica
San Diego
San Diego-based.
Series DCapstan Therapeutics
San Diego
San Diego-based.
Series BRxSight
Aliso Viejo
Aliso Viejo-based.
Venture RoundPyxis Oncology
Boston
Boston-based.
Series BZura Bio
Henderson
Henderson-based.
Post IPO EquityVaxess Technologies
Cambridge
Cambridge-based.
Venture RoundTasso
Seattle
Seattle-based.
Series BEverest Medicines
New York
New York-based.
Series CElektrofi
Boston
Boston-based.
Series CEnara Bio
Oxford
Oxford-based.
Series BProtara Therapeutics
New York
New York-based.
Post IPO EquityVerve Therapeutics
Boston
Boston-based.
Series BAsher Bio
San Francisco
San Francisco-based.
Series CBe Biopharma
Cambridge
Cambridge-based.
Series CAmbAgon Therapeutics
San Francisco
San Francisco-based.
Series AAzalea Therapeutics
Berkeley
Berkeley-based.
Seed RoundAltruBio
Los Altos
Los Altos-based.
Series BXilio Therapeutics
Waltham
Waltham-based.
Series COutpace Bio
Seattle
Seattle-based.
Series BPluton Biosciences
Saint Louis
Saint Louis-based.
Series AAvidity Biosciences
San Diego
San Diego-based.
Post IPO EquityAM Batteries
Chelmsford
Chelmsford-based.
Series BNTx
Rio Rancho
Rio Rancho-based.
Series BRivus Pharmaceuticals
Charlottesville
Charlottesville-based.
Series BCarmot Therapeutics
Berkeley
Berkeley-based.
Series EVesta Healthcare
New York
New York-based.
Series CCidara Therapeutics
San Diego
San Diego-based.
Post IPO EquityAltimmune
Gaithersburg
Gaithersburg-based.
Post IPO EquityApeiron labs
Cambridge
Cambridge-based.
Series ACommons Clinic
Los Angeles
Los Angeles-based.
Series BAavantiBio
Cambridge
Cambridge-based.
Series AMariana Oncology
Watertown
Watertown-based.
Series BArvinas
New Haven
New Haven-based.
Post IPO EquityGenetix Biotherapeutics Inc.
Somerville
Somerville-based.
Series DIndapta Therapeutics
San Francisco
San Francisco-based.
Venture RoundAiolos Bio
San Francisco
San Francisco-based.
Series ANodexus
San Jose
San Jose-based.
Series ASurrozen
South San Francisco
South San Francisco-based.
Post IPO EquityCerebral Therapeutics
Aurora
Aurora-based.
Series CBraeburn
Plymouth Meeting
Plymouth Meeting-based.
Debt FinancingDTx Pharma
San Diego
San Diego-based.
Series BBicycle Therapeutics
Cambridge
Cambridge-based.
Post IPO EquitySANUWAVE Health
Alpharetta
Alpharetta-based.
Post IPO EquityWerewolf Therapeutics
Cambridge
Cambridge-based.
Series BOvid Therapeutics
New York
New York-based.
Post IPO EquityEquillium
La Jolla
La Jolla-based.
Post IPO EquityMonopar
Wilmette
Wilmette-based.
Post IPO EquityCiVi Biopharma
Chevy Chase
Chevy Chase-based.
Venture RoundTeraPore Technologies
South San Francisco
South San Francisco-based.
Venture RoundMedicenna Therapeutics
Toronto
Toronto-based.
Post IPO EquityEledon Pharmaceuticals
Irvine
Irvine-based.
Post IPO EquityFORMA Therapeutics
Watertown
Watertown-based.
Series DPoint Biopharma
Indianapolis
Indianapolis-based.
Post IPO EquityConnect Biopharmaceuticals
Taicang
Taicang-based.
Series CITeos Therapeutics
Cambridge
Cambridge-based.
Post IPO EquityEidos Therapeutics
Palo Alto
Palo Alto-based.
Series BBellicum Pharmaceuticals
Houston
Houston-based.
Series CAthersys
Cleveland
Cleveland-based.
Venture RoundJohnson & Johnson Innovative Medicine
Beerse
Beerse-based.
Seed RoundGenelabs Technologies
Redwood City
Redwood City-based.
Venture RoundZS Pharma
Coppell
Coppell-based.
Series DCovid Apollo Project
Boston
Boston-based.
Seed Round
Intarcia Therapeutics
Boston
We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking.
Biotechnology ResearchEst. 1997- DP
Dicerna Pharmaceuticals
Lexington
Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.
Pharmaceutical ManufacturingEst. 2007
More portfolio companies
55 more RA Capital Management investments we track beyond the map — 150 tracked in total.
BioAge LabsRichmond · Series D
Nimbus TherapeuticsBoston · Private Equity
Triana BiomedicinesLexington · Series B
Nautilus BiotechnologySan Carlos · Post-IPO Equity
Terremoto BiosciencesSan Francisco · Series C
Aktis OncologyBoston · Series B
NateraSan Carlos · Series F
Acumen PharmaceuticalsCarmel · Post-IPO Equity
Design TherapeuticsSolana Beach · Series B
Tyra BiosciencesCarlsbad · Post-IPO Equity
Halda TherapeuticsNew Haven · Series B
Bristol-Myers SquibbNew York · Post-IPO Equity
TScan TherapeuticsWaltham · Series C
Stylus MedicineCambridge · Series A
Angitia BiopharmaceuticalsWestlake Village · Series D
Verdiva BioLondon · Series A
ExoRedwood City · Series C
Boundless BioLa Jolla · Series C
Akari TherapeuticsLondon · Post-IPO Equity
EmpaticaCambridge · Series B
NanoMosaicWaltham · Series A
SynthekineMenlo Park · Series B
Bia EnergyBogotá · Convertible Note
Zai LabShanghai · Post-IPO Equity
Edgewise TherapeuticsBoulder · Post-IPO Equity
ExcepGenSan Francisco · Seed
Sortera TechnologiesFort Wayne · Series C
Sionna TherapeuticsNatick · Series C
Ascendis PharmaPalo Alto · Series D
KalVista PharmaceuticalsCambridge · Series B
AbcuroNewton · Series C
ArdelyxFremont · Post-IPO Equity
Prelude TherapeuticsWilmington · Post-IPO Equity
AdelaFoster City · Series A
Vivace TherapeuticsSan Mateo · Series D
Third Harmonic BioCambridge · Series B
Ventus TherapeuticsWaltham · Series C
Magenta MedicalKadima · Venture
C4 TherapeuticsCambridge · Post-IPO Equity
NucleixRehovot · Venture
T-knifeBerlin · Series B
Aurinia PharmaceuticalsVictoria · Post-IPO Equity
LianBioShanghai · Series A
Iterum TherapeuticsDublin · Post-IPO Equity
89bioSan Francisco · Series A
Sierra OncologySan Mateo · Series D
Regulus TherapeuticsSan Diego · Post-IPO Equity
AkouosBoston · Series B
Adeo Health ScienceBoston · Seed
Ra PharmaceuticalsCambridge · Series B
Pandion TherapeuticsCambridge · Series B
Aimmune TherapeuticsBrisbane · Series B
ImaraCambridge · Series B
ThriveworksLynchburg · Venture
AmpliPhi BiosciencesRichmond · Post-IPO Equity